ThermoGenesis posts a narrower net loss
02/13/2013 12:00 AM
02/13/2013 8:04 AM
Rancho Cordova-based medical equipment firm ThermoGenesis Corp. reported a loss of $563,000, or 3 cents a share, in its fiscal second quarter ended Dec. 31.
That was an improvement from a loss of $1.3 million, or 8 cents a share, in the year-ago period.
ThermoGenesis said quarterly revenue was $4.8 million, slightly better than about $4.7 million in the same quarter of 2011.
Over the past year, ThermoGenesis has been selling off some product lines in order to concentrate on its cord blood and bone marrow stem cell processing/storage business.
Join the Discussion
The Sacramento Bee is pleased to provide this opportunity to share information, experiences and observations about what's in the news. Some of the comments may be reprinted elsewhere on the site or in the newspaper. We encourage lively, open debate on the issues of the day, and ask that you refrain from profanity, hate speech, personal comments and remarks that are off point. Thank you for taking the time to offer your thoughts.